Robert Egge

Executive Director, AIM

Chief Public Policy Officer, Alzheimer's Association

Robert Egge is the chief public policy officer of the Alzheimer's Association and the executive director of the Alzheimer's Impact Movement (AIM). In these roles, Egge oversees government affairs, policy development and grassroots advocacy teams working to secure policies to improve the lives of all those affected by dementia.

Since joining the organization in 2009, Egge has led the Association in achieving several major milestones in Alzheimer's policy, including the passage of the National Alzheimer's Project Act (NAPA), which mandated the creation of the first national plan to fight Alzheimer's. He managed the Association's efforts to enact the bipartisan BOLD infrastructure for Alzheimer's Act, legislation that is critical to addressing Alzheimer's as a public health issue. Under Egge's guidance, the Association has successfully lobbied Congress for significant increases in funding for Alzheimer's disease research, more than quadrupling funding levels since the passage of NAPA.

Egge also drove the Association's support for a 2016 decision by the Centers for Medicare & Medicaid Services to ensure people with Alzheimer's have access to care planning with a medical professional through Medicare for the first time in history. In addition, Egge has overseen efforts to increase the number of state Alzheimer's plans so the disease can be more effectively addressed on the local level. Today, 46 states plus the District of Columbia and Puerto Rico have plans in place.

Egge was appointed to the U.S. Department of Health and Human Services' Advisory Council on Alzheimer's Research, Care, and Services in 2017. This advisory council, created by the National Alzheimer's Project Act, provides guidance to both the secretary and the United States Congress on matters of Alzheimer's policy.

Prior to joining the Alzheimer's Association, Egge served as executive director of the Alzheimer's Study Group, a blue-ribbon task force co-chaired by former House Speaker Newt Gingrich and former Nebraska Senator Bob Kerry. Egge led the group in a review of the challenges posed by the mounting Alzheimer's crisis, and managed the development of the group's national assessment, strategy and specific policy proposals.

Egge's articles and editorials have appeared in a variety of publications including The New York Times, the Financial Times and Health Affairs. He is often invited to testify before Congress on Alzheimer's issues, and frequently speaks on Alzheimer's policy through television, radio and print interviews.

The Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. For more information, visit

Recent Posts
Protecting Our Most Vulnerable
May 19, 2020
Alzheimer's: A 2018 Election Issue
November 5, 2018
Exciting Alzheimer’s Research Presented in Chicago
July 26, 2018
Bold Action on Alzheimer's
June 12, 2018
Taking the Case to Congress
April 26, 2018
FDA Issues Draft Guidance on Alzheimer's drug development
February 16, 2018
AIM, Alzheimer’s Association Appeal for Increased Federal Research Funding at NIH Answered
May 5, 2017
Continuing to Drive the Pace of Alzheimer's Research
March 14, 2017
Ronald Reagan Fought Alzheimer's - Congress Can Honor His Legacy by Doing the Same
February 6, 2017
An Open Letter to HHS Secretary Nominee Tom Price
January 13, 2017
Welcome to Washington Mr. Trump and the 115th Congress
January 6, 2017
New Year, New Look, Same Commitment
December 29, 2016
Support for the 21st Century Cures Act
November 30, 2016
Alzheimer's Research: Where We've Failed and What's to Come
November 29, 2016
Looking Ahead to the Trump Administration and the 115th Congress
November 16, 2016
Campaign 2016 - The Year Alzheimer's Became a Campaign Trail Priority
November 8, 2016
AIM Supports Congressional Champions in Re-Election Bids
October 29, 2016
Honoring an Alzheimer's Champion
October 13, 2016
The Research Speaks, but Will Congress Listen in its Fight Against Alzheimer's Disease
August 15, 2016
Live from Philly
July 24, 2016
Live from Cleveland
July 18, 2016
Alzheimer's Fight Offers Rare Opportunity for Bipartisanship
July 7, 2016
Without Action, Alzheimer's Will Overwhelm Federal Budget by 2050 (Part III)
June 30, 2016
Without Action, Alzheimer's Will Overwhelm Federal Budget by 2050 (Part II)
June 23, 2016
Without Action, Alzheimer's Will Overwhelm Federal Budget by 2050 (Part I)
June 16, 2016